We posit that urinary levels of these proteins (e.g., calcineurin, cyclophilin A, 14-3-3 family proteins) may serve as useful indicators of clinical remission in LN, where renal pathology AI is also reduced, particularly in patients treated with calcineurin inhibitors. The gene discussed is PPIA; the disease is lobular neoplasia.